Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.40 |
| ▸ | DHODH | Q02127 | 2/20 | 0.40 |
| ▸ | INPPL1 | O15357 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | MRGPRX4 | Q96LA9 | 3/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | P2RX7 | Q99572 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18515267 | 0.93 | TP53 (0.41) | TP53ALDH1A1POLBSMN1; SMN2DHODH | |
| SCHEMBL18749647 | 0.90 | SLC22A12 (0.43) | ALDH1A1SMN1; SMN2RAB9AMRGPRX4P2RX7 | |
| SCHEMBL18749859 | 0.90 | KMT2A (0.41) | TP53ALDH1A1LMNAMRGPRX4 | |
| SCHEMBL18749892 | 0.90 | MRGPRX4 (0.39) | TP53ALDH1A1LMNARAB9AMRGPRX4 | |
| SCHEMBL18749862 | 0.90 | MAPT (0.44) | TP53ALDH1A1SMN1; SMN2LMNARAB9A | |
| SCHEMBL18749980 | 0.89 | MRGPRX4 (0.40) | SMN1; SMN2RAB9AMRGPRX4 | |
| SCHEMBL18749782 | 0.88 | MRGPRX4 (0.47) | TP53ALDH1A1POLBDHODHMRGPRX4 | |
| SCHEMBL18749701 | 0.88 | MRGPRX4 (0.38) | RAB9AMRGPRX4 | |
| SCHEMBL18749678 | 0.88 | SMN1; SMN2 (0.46) | ALDH1A1POLBSMN1; SMN2DHODHINPPL1 | |
| SCHEMBL18749787 | 0.87 | MRGPRX4 (0.38) | RAB9AMRGPRX4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9907307-B2 | Aromatic compound and uses thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2018-03-06 | — | — | US | disclosed |
| US-9788547-B2 | Aromatic compound and uses thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-10-17 | — | — | US | disclosed |
| US-20170105413-A1 | AROMATIC COMPOUND AND USES THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-04-20 | — | — | US | disclosed |
| US-20170105416-A1 | AROMATIC COMPOUND AND USES THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-04-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170105413-A1 | AROMATIC COMPOUND AND USES THEREOF | TYR, H1-3, H1-0 | TP53 1248/4885ALDH1A1 1238/4885POLB 4673/4885 |
| US-20170105416-A1 | AROMATIC COMPOUND AND USES THEREOF | TYR, H1-3, H1-10 | TP53 1755/4885ALDH1A1 1416/4885POLB 4487/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.